Positive ASE (n = 92) | Negative ASE (n = 211) | p | |
---|---|---|---|
Age (years) | 49.5 ± 10.8 | 53.8 ± 8.1 | 0.001 |
Male gender | 60 (65.0%) | 139 (65.9%) | 1.000 |
SBP (mmHg) | 124.9 ± 17.2 | 127.3 ± 16.2 | 0.257 |
DBP | 76.8 ± 12.5 | 76.9 ± 10.4 | 0.971 |
Heart rate (bpm) | 69.3 ± 11.2 | 67.2 ± 10.4 | 0.108 |
Body mass index (kg/m2) | 24.1 ± 3.3 | 25.0 ± 3.9 | 0.046 |
Brain MRI | 0.331 | ||
TIA | 18 (19.6%) | 25 (11.8%) | |
Acute stroke | 53 (57.6%) | 146 (69.2%) | |
Small vessel disease | 8 (8.7%) | 17 (8.1%) | |
Undetermined | 13 (14.1%) | 20 (10.9%) | |
Any abnormality | 61 (66.3%) | 163 (77.3%) | 0.046 |
Brain MRA | 0.282 | ||
Normal | 41 (48.8%) | 85 (40.5%) | |
Aneurysm | 14 (16.7%) | 363 (17.1%) | |
Stenosis | 31 (36.9%) | 101 (48.1%) | 0.092 |
Vasculitis et al | 5 (6.0%) | 7 (3.3%) | |
Thrombolysis | 2 (1.7%) | 10 (5.6%) | 0.133 |
Hypertension | 28 (30.4%) | 92 (43.6%) | 0.041 |
Diabetes | 15 (16.3%) | 46 (21.8%) | 0.350 |
Prior events | 8 (8.7%) | 26 (12.3%) | 0.432 |
RoPE score | 5.73 ± 1.51 | 4.99 ± 1.54 | < 0.001 |
Current smoker | 43 (46.7%) | 95 (45.0%) | 0.803 |
Medications | |||
Aspirin | 1 (1.1%) | 18 (8.6%) | 0.010 |
RASB | 15 (16.3%) | 40 (19.0%) | 0.629 |
Statin | 8 (8.7%) | 28 (13.3%) | 0.335 |
aPFO device therapy | 6 (6.6%) | 0 | 0.001 |
Recurrence | 4 (4.7%) | 13 (6.2%) | 0.407 |
Loss of follow up | 1(1.1%) | 34 (16.1%) | 0.001 |